Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 37,000 shares at $3.00 ($111K) on 2017-04-04, disclosed to the SEC on 2017-04-05.
Open-market sale of $111k ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2019-12-11 | $1.4M | — | Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2019-12-11 | $279K | — | Filing → |